Federal Reserve‘s “endless QE” cheers markets
America's Federal Reserve has slashed interest rates and launched unprecedented bond-buying programmes that stretched its mandate to its limits. More could be in store next year.

The post-election stockmarket is a “Labrador”, writes Ben Wright in The Daily Telegraph. Like the dog breed, it is proving “monomaniacally cheerful irrespective of circumstances”. Global markets had perked up in the days before the US election; polls suggested a Democratic blue wave would open the way for a $2.2trn stimulus package.
Yet when it became clear that Florida and Texas would not be painted blue, markets didn’t retreat. Instead, they decided that a Biden White House combined with a Republican Senate was what they had wanted all along. As the world waited for a final election call, the S&P 500 gained 7.3%, its best weekly performance since April.
A Biden White House with a Republican Senate is good news for US stocks, Andy LaPerriere of Cornerstone Macro told Barron’s. The Senate will block Democrat tax hikes on business, while a Biden administration should bring greater calm on the trade war front. The idea that divided government is good for equities is something of a Wall Street cliché. Yet there is little evidence for the idea that it is best when opposing parties are in Congress and the White House, says Paul Vigna in the Wall Street Journal. Since 1928 “there has been virtually no difference in the annual return of the S&P 500” between years with united and divided governments. If fact, stocks “slightly outperformed” when the executive and the legislature were in the same hands.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The almighty Fed
British stocks managed an even more impressively Panglossian feat, notes Philip Aldrick in The Times. The FTSE 100 gained more than 6% last week despite the small matter of England returning to a nationwide lockdown. In a world where fresh quantitative easing (QE)is always available, “bad news is no longer bad news… because policymakers won’t allow it”. In 2008 the banks were “too big to fail”, now that is true of the entire market. Central bankers won’t admit it openly, but there is a “price floor for assets… Call it market welfare for financiers”. The Federal Reserve last week agreed to keep interest rates at between 0% and 0.25% and continue its monthly purchases of $120bn-worth of bonds and mortgage-backed securities with printed money. The Fed’s balance sheet has soared from $4.1trn before the pandemic began to $7.1trn today, equivalent to 34% of 2019 US GDP.
Federal Reserve chairman Jerome Powell has done more than any politician to stabilise the markets this year, says Nicholas Jasinski in Barron’s. In the spring he slashed interest rates and launched unprecedented bond-buying programmes that stretched the Fed’s mandate to its limits. More could be in store next year. For investors, it is Jerome Powell, not Joe Biden, who is the man to watch in 2021.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Reeves warned against property tax shake-up – 3 ways it could backfire on first-time buyers
Rachel Reeves reportedly has her eye on high-end property taxes in the upcoming Budget, but there are concerns a shake-up could unintentionally hamper those trying to get on the housing ladder
-
Average Brits want to retire five years before they can – who has the widest retirement gap?
Brits are expecting to work for longer than ever but there are big disparities in the number of extra working years predicted. A small tweak could help close the gap
-
Pierre-Édouard Stérin wants to make France great again
Conservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growth
Pinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'
Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with follies
The best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuation
AEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?